Dempze Nancy E
- SEC CIK
- 0001592614
- Latest filing
- Aug 12, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Dempze Nancy E, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −2,985−100.0% | Sold out | Holders |
| Q3 2023 | 2,985 | $206.8K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 2,985 | $281.6K | 0.2% | +200+7.2% | Added | Holders |
| Q1 2023 | 2,785 | $230.4K | 0.2% | +2,785 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −2,685−100.0% | Sold out | Holders |
| Q3 2022 | 2,685 | $222.0K | 0.2% | −482−15.2% | Reduced | Holders |
| Q2 2022 | 3,167 | $301.0K | 0.3% | +1,040+48.9% | Added | Holders |
| Q1 2022 | 2,127 | $250.0K | 0.2% | +477+28.9% | Added | Holders |
| Q4 2021 | 1,650 | $214.0K | 0.1% | +1,650 | New | Holders |